Netherlands· NL-1b21b317f791
Rennie, kauwtabletten
A kombinationen von aluminium-, calcium- und magnesiumsalzen product containing calciumcarbonaat (e 170) + magnesiumcarbonaat, zwaar (e 504 (ii)), registered in Netherlands by Top-Pharma B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Kombinationen von aluminium-, calcium- und magnesiumsalzen is registered in 10 of 19 countries.
Countries holding a registration under ATC A02AD01 (kombinationen von aluminium-, calcium- und magnesiumsalzen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Kombinationen von aluminium-, calcium- und magnesiumsalzen · ATC A02AD01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CALCIUMCARBONAAT (E 170) + MAGNESIUMCARBONAAT, ZWAAR (E 504 (II))
- Manufacturer
- Top-Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- A02AD01
- ATC class
- Kombinationen von Aluminium-, Calcium- und Magnesiumsalzen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132921//08892
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
16 interactions on record for kombinationen von aluminium-, calcium- und magnesiumsalzen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Kombinationen von aluminium-, calcium- und magnesiumsalzen · interactions on record
16 records
16 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A02AD01
Kombinationen von aluminium-, calcium- und magnesiumsalzen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9e72330-f663-41a2-8b72-3a0131f63202 GET /v1/drugs/f9e72330-f663-41a2-8b72-3a0131f63202?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kauwtablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08892_smpc.pdf",
"strength": null,
"atc_label": "Ordinary Salt Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132921",
"excipients": [
"GLUCOSE 0-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"PEPERMUNTSMAAKSTOF",
"POVIDON (E 1201)",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"SACCHAROSE",
"TALK (E 553b)"
],
"substances": [
"CALCIUMCARBONAAT (E 170)",
"MAGNESIUMCARBONAAT, ZWAAR (E 504 (II))"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132921.pdf",
"authorised_at": "2024/04/22",
"procedure_number": null,
"dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 1 februari 2024]",
"registration_number": "132921//08892",
"additional_monitoring": "N"
}See everything about kombinationen von aluminium-, calcium- und magnesiumsalzen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.